Buparlisib (BKM120)

For research use only. Not for use in humans.

目录号:S2247 别名: NVP-BKM120 中文名称:布帕尼西

Buparlisib (BKM120) Chemical Structure

CAS No. 944396-07-0

Buparlisib (BKM120, NVP-BKM120) 是一种选择性 PI3K 抑制剂,在无细胞试验中作用于p110α/β/δ/γIC50分别为 52 nM/166 nM/116 nM/262 nM。对 VPS34,mTOR,DNAPK 的作用效果下降,而对 PI4Kβ几乎没有活性。Buparlisib 可诱导凋亡。Phase 2。

规格 价格 库存 购买数量  
10mM (1mL in DMSO) RMB 2227.95 现货
RMB 1400.12 现货
RMB 2607.65 现货
RMB 7928.28 现货
有超大折扣

今日订购,明日送达,全国免运费!

全国免费电话:400-668-6834   |   Email:info@selleck.cn

客户使用Selleck生产的Buparlisib (BKM120)发表文献212篇:

产品安全说明书

PI3K抑制剂选择性比较

生物活性

产品描述 Buparlisib (BKM120, NVP-BKM120) 是一种选择性 PI3K 抑制剂,在无细胞试验中作用于p110α/β/δ/γIC50分别为 52 nM/166 nM/116 nM/262 nM。对 VPS34,mTOR,DNAPK 的作用效果下降,而对 PI4Kβ几乎没有活性。Buparlisib 可诱导凋亡。Phase 2。
特性 BKM120是可用于口服的生物有效的PI3K抑制剂。
靶点
p110α [1]
(Cell-free assay)
p110δ [1]
(Cell-free assay)
p110β [1]
(Cell-free assay)
p110γ [1]
(Cell-free assay)
Vps34 [1]
(Cell-free assay)
52 nM 116 nM 166 nM 262 nM 2.4 μM
体外研究

BKM120作用于解除PI3K调节的细胞系,包括A2780, U87MG, MCF7和DU145时,具有抗增殖活性,GI50为0.1-0.7 nM。[1] BKM120诱导多发性骨髓瘤细胞(ARP1, ARK, MM.1S, MM1.R和U266)凋亡,导致G1期细胞增多,S期细胞减少。BKM120诱导CD138+原代MM 细胞凋亡,且作用于CD138−基质细胞时毒性较低。BKM120可引起BimS的上调和XIAP的下调。[2]BKM120作用于人类胃癌细胞系,降低mTOR下游信号,具有抗增殖活性。BKM120作用于KRAS突变的胃癌细胞系,可以增强p-ERK或 p-STAT3。BKM120 和STAT3阻断剂联用, 作用于含突变KRAS的细胞,诱导凋亡,具有协同效应,但是作用于KRAS野生型细胞没有这种效果。[3]BKM120主要通过Aurora B激酶调节有丝分裂崩坏。[4]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
glioma cell lines NGX6c|RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MWG3Nog> NIT4RYZKSzVyPUGtNu69VQ>? NVTPW3BlRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkKwOlUxQDBpPkKyNFY2ODhyPD;hQi=>
U87 MVPBdI9xfG:|aYOgRZN{[Xl? NHrXfWYz|ryP NH3PV3U4Omh? NVeyXZdycW6mdXPld{Bk\WyuIHHwc5B1d3OrczDhcoQh[2ynYY\l[EBRSVKSIHHu[EBk[XOyYYPlMVM> M2nC[lxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{ME[1NFgxLz5{MkC2OVA5ODxxYU6=
SNU-601 M4HuVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M32wNVczcA>? NYjtbmVWTE2VTx?= MW\JR|UxRTBwOEG2xtExNjB4M988US=> NWfKe45ERGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkKxOVk5OTRpPkKyNVU6QDF2PD;hQi=>
SNU-1 NHj6NodIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFjuWno4Omh? M2nPZ2ROW09? MkjITWM2OD1zLkC4NuKyOC5yMklOwG0> MUG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjF3OUixOEc,OjJzNUm4NVQ9N2F-
SNU-668 M2e0WGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NFnHZ2w4Omh? NGnzc2NFVVOR M3;lbGlEPTB;MT61O|nDuTBwMEe0{txO NFnlUWI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkG1PVgyPCd-MkKxOVk5OTR:L3G+
AGS NIfUUItIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFnBdlE4Omh? M{e2SWROW09? MVnJR|UxRTFwN{G0xtExNjFzN988US=> M{e2e|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{MUW5PFE1Lz5{MkG1PVgyPDxxYU6=
SNU-216 NEjlfY1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXy3Nog> MXzEUXNQ NXriOpJUUUN3ME2yMlY6OsLzMD6wPFLPxE1? NWK4WppvRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkKxOVk5OTRpPkKyNVU6QDF2PD;hQi=>
SNU-5 MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{TTb|czcA>? NEfpeIZFVVOR NXnnTnNyUUN3ME2xMlM2OcLzMD6wPVHPxE1? NWCzUJVmRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkKxOVk5OTRpPkKyNVU6QDF2PD;hQi=>
SNU-638 MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M3HXZlczcA>? MUPEUXNQ M{jaVWlEPTB;Mj6yPFLDuTBwMEWz{txO MnmwQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJzNUm4NVQoRjJ{MUW5PFE1RC:jPh?=
SNU-16 NGS0d|VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYi3Nog> M2jifGROW09? NUL5Z45XUUN3ME2xMlU4O8LzMD6wNFHPxE1? NEWxeJo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkG1PVgyPCd-MkKxOVk5OTR:L3G+
SNU-484 NEnkV25Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NW\DeY54PzKq NF3zRY9FVVOR M{fCPWlEPTB;MT63NljDuTBwMES1{txO MVu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjF3OUixOEc,OjJzNUm4NVQ9N2F-
SNU-620 MkniS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoTzO|Jp NY\sRnhFTE2VTx?= NXnlSXM5UUN3ME2yMlk{QcLzMD6wNFHPxE1? MmS2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJzNUm4NVQoRjJ{MUW5PFE1RC:jPh?=
SNU-719 MorZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NF\ieo44Omh? Ml;ISG1UVw>? NGPn[5lKSzVyPUOuNFM4yrFyLkCzNu69VQ>? MmfzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJzNUm4NVQoRjJ{MUW5PFE1RC:jPh?=
MM cell lines NVXSN2N2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWjFNXlPOTEQvF2= NFrhb|gzPGh? NUXmbox6TE2VTx?= NIrrZnFKSzVyII\hdolmeyCjbX;u[{BlcW[oZYLlcpQh[2WubDDsbY5meyCrbjD0bY1mKGGwZDDkc5NmKGSncHXu[IVv[2V? MWS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjJyN{S4OUc,OjJ{MEe0PFU9N2F-
ARP-1 NEjVU4VCeG:ydH;zbZMhSXO|YYm= NX20eoJKOTEQvF2= MY[yOIg> NHuxeYJFVVOR Mon2bY5lfWOnczDNUUBk\WyuIHHwc5B1d3OrczD0bJJwfWeqIHPhd5Bie2ViYXP0bZZifGmxbh?= M2rI[FxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{MkC3OFg2Lz5{MkKwO|Q5PTxxYU6=
colon cancer cell lines NV;ES5A3T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MlTnNE0yOM7:TR?= MoTFO|Jp MmXKSG1UVw>? Mn\lTWM2OD1zzszN NV30[no2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK1OFM5PTdpPkKyOVQ{QDV5PD;hQi=>
gastric cancer cell lines NXm4ZW5pT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NHzwOHkxNTFyzszN MV[3Nog> MnTlSG1UVw>? NVTrOpE{UUN3ME2yMVXPxE1? NUXBOWRRRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK1OFM5PTdpPkKyOVQ{QDV5PD;hQi=>
HCT-116/HT-29/MKN-45 Ml;tRZBweHSxc3nzJGF{e2G7 MYCy{txO NIrHVHE1QGh? Mnrad4hq\nRiaX6gS|IheGijc3W= M2DNZVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{NUSzPFU4Lz5{MkW0N|g2PzxxYU6=
HT-29 and HCT-116 MVfDZZNx[XOnIHHzd4F6 MoTTOe69VQ>? M1HaSVI1cA>? NGfxO|VqdmS3Y3XzJINie3Cjc3WgZYN1cX[rdIm= MUC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjV2M{i1O{c,OjJ3NEO4OVc9N2F-
PIK3CA-mutant MCF7 Mn\2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUTnW5prT0l3ME2xOlDDuTlzbl5vwKxNTDVyPUm4NOKyOjd|bl2= NUfxTGxiPzKq Mn7JS2k2OD1zNkFCtVkydk4xvJzMSFUxRTl6MNMxNlc{dk1? MV[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjZ3M{m2O{c,OjJ4NUO5Olc9N2F-
PIK3CA-mutant MCF7 MnvCT4lv[XOnIFHzd4F6 NXjt[odWUUN3ME2xNVTDuTOwTR?= NXLiWpNtPzKq NFvhUFBKSzVyPUGxOOKyO26PIHnuJJJm\HWlaX7nJGFsfCCyaH;zdIhwenmuYYTpc44hdGW4ZXzz NWjHSXdLRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK2OVM6PjdpPkKyOlU{QTZ5PD;hQi=>
MCF7-myr-Akt Ml\GS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M1;KfGdKPTB;Mkm5xtE3QG6P78{MUGQ2OO,:nkGwMFAxOG6P MXm3Nog> M3\BRWdKPTB;Mkm5xtE3QG6P78{MUGQ2OO,:nkGwMFAxOG6P NEW3U2U9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{Mk[1N|k3Pyd-MkK2OVM6Pjd:L3G+
Y1 cell line MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVT1cJRsOC5zzszNM|HPxE1? NIrTWJozPGh? NFH2e2tFVVOR MX7pcohq[mm2czC2NQ+9jSClZXzsJJZq[WKrbHn0fUBqdiCPeXOtV4N1ei22cnHud4Zm[3SnZDDj[Yxtew>? MVq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjZ7MkmwOEc,OjJ4OUK5NFQ9N2F-
human NSCLC NWLieYRYT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWntToRwOC53LUNOwG0> M2XuT|czcA>? NGL0TmtKSzVyPUJOwG0> M3zZT|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{N{ixN|k{Lz5{Mke4NVM6OzxxYU6=
human NSCLC Ml;RT4lv[XOnIFHzd4F6 MVOx{txO M{\5[|I1cA>? M1na[IlvcGmkaYTzJJRp\SCDa4SvcXRQWiC|aXfuZYxqdmdicHH0bJdigSCjdDCzbEBi\nSncjD0doVifG2nboS= Mnj3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ5OEGzPVMoRjJ{N{ixN|k{RC:jPh?=
JVM2 MonoR5l1d3SxeHnjbZR6KGG|c3H5 MY[wMlIuOjEQvF2= NGfLZXY4Omh? NWjCUIh3TE2VTx?= MoTITWM2OD1yLkpOwG0> NXfQNGFRRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOyN|g3OzlpPkKzNlM5PjN7PD;hQi=>
EHEB NFrF[VFEgXSxdH;4bYNqfHliYYPzZZk> MXewMlIuOjEQvF2= M2jJ[lczcA>? MnHZSG1UVw>? Mmj1TWM2OD1yLkhOwG0> M1n3U|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|MkO4OlM6Lz5{M{KzPFY{QTxxYU6=
MEC2 MmjLR5l1d3SxeHnjbZR6KGG|c3H5 NWjtdmxrOC5{LUKw{txO NHvkSJg4Omh? MorOSG1UVw>? M4fWc2lEPTB;MD63{txO NGGzVlk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{KzPFY{QSd-MkOyN|g3Ozl:L3G+
primary B-CLL lymphocytes MXXBdI9xfG:|aYOgRZN{[Xl? NID1b5lKSzVyIH\vdkBm[WOqIIDybY1ienliY3XscEBtcW6n NYWzfpVLOjSq MVLEUXNQ NHO4bYNKSzVy78{cN:69VSCob4KgZYxtKHCjdHnlcpR{ MX28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzJ|OE[zPUc,OjN{M{i2N|k9N2F-
primary B-CLL lymphocytes MmHQT4lv[XOnIFHzd4F6 NGHXNopKSzVyIH\vdkBm[WOqIIDybY1ienliY3XscEBtcW6n MVeyOIg> MVLpcohq[mm2czDwO|BUPktiJjC0SU1DWDFiZYjwdoV{e2mxbh?= NX22V25jRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOyN|g3OzlpPkKzNlM5PjN7PD;hQi=>
SK-HEP1 MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NITHWZMyNTJyzszN MXG3Nog> M{K2PWROW09? NFf1NplKSzVy78{cNe69VQ>? MYe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzR5OUGzOkc,OjN2N{mxN|Y9N2F-
786-0 NWLkOHh7T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MX6xMVIx|ryP MVu3Nog> NXLsbWQ2TE2VTx?= M2XzdmlEPTExvKyx{txO NWDNb21XRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO0O|kyOzZpPkKzOFc6OTN4PD;hQi=>
human HCC cell lines NH7SdlVE\WyuII\pZYJqdGm2eTDhd5NigQ>? Mn\0NE4xODVvMd88US=> MYG0PIg> NUe5O2VzUUN3ME2x{txO MkW3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN2OEm5PVkoRjJ|NEi5PVk6RC:jPh?=
Huh7 NWHrSXh3U2mwYYPlJGF{e2G7 M33iXVHPxE1? Ml7DOFhp MWLzbYdvce,ugXPhcpRtgSC{ZXT1Z4V{KHCqb4PwbI9zgWyjdHnvckBw\iCDa4S= NYflc3kyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO0PFk6QTlpPkKzOFg6QTl7PD;hQi=>
human NSCLC cell lines MYHBdI9xfG:|aYOgRZN{[Xl? NX;5ZZN5OC5zMkWtOO69VQ>? NHPnNnIzPGh? NWrYNGtHTE2VTx?= NWPmXVZZUUN3MIOgdoFv\2W|IH\yc40hOC52LUNOwG0> MljhQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN3NkK0O|IoRjJ|NU[yOFczRC:jPh?=
Primary CLL cells NXjDU4pWSXCxcITvd4l{KEG|c3H5 MnXjNU0yOM7:TR?= M2fib|Q5cA>? MWXpcoR2[2W|IHHwc5B1d3OrczDpckBEVExiY3XscJMhcW6mZYDlcoRmdnRib3[gdJJw\26xc4TpZ{Bu[XKtZYLz Mn;uQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN6NUC4NFcoRjJ|OEWwPFA4RC:jPh?=
Primary CLL cells NUfTfINSU2mwYYPlJGF{e2G7 Ml3YNu69VQ>? MnLiN|BucW5? MlLK[IVkemWjc3XkJHBKO0tiYXP0bZZqfHl? MmLxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN6NUC4NFcoRjJ|OEWwPFA4RC:jPh?=
Primary CLL cells NE\HUIVEgXSxdH;4bYMhSXO|YYm= M1;GWVLPxE1? Mn7YNlRp MnH4bY5lfWOnczDj[YxtKGO7dH;0c5hq[2m2eR?= NWWxe4s1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO4OVA5ODdpPkKzPFUxQDB5PD;hQi=>
LC-1/SQSF M2HIc2Z2dmO2aX;uJGF{e2G7 MkHVN:69VQ>? MkSwNlRp MVXEUXNQ M3\hcoRm[3KnYYPlJG5TTjJicILveIVqdiCuZY\lcC=> MVm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzl6MEC5N{c,OjN7OECwPVM9N2F-
BCR-ABL M{i4TGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mo\ZNE4zPS1zMN88US=> M4TEdVRl M{PzSpNq\26rZnnjZY51dHliaX7obYJqfCClZXzsJJBzd2yrZnXyZZRqd25? MnSwQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR{NES2NVIoRjJ2MkS0OlEzRC:jPh?=
T-ALL NUKzRlhiSXCxcITvd4l{KEG|c3H5 NGW0bYlj\XS5ZXXuJFEvPCCjbnSgOU4{KG2PIHH0JFI1cCCjbnSgNE46KGGwZDC1MlUhdU1iYYSgOFhpKGmwIHTp[oZmemWwdDDj[YxtKGyrbnW= NWfl[ot1OjRib4KgOFhp NYPUfoE5TE2VTx?= MmLNZYZn\WO2czD0bIUhWEl|SzDwZZRpf2G7IHnuJHQuSUyOIHPlcIwhdGmwZYO= M3vWZlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2M{GwO|M3Lz5{NEOxNFc{PjxxYU6=
H1975 NWDXfI44T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NE\hWIsxNjNvOT62{txO NVHhSXFWPzKq M4\uPGROW09? MoLSTWM2OD1zLkO4Oe69VQ>? NUnhSllMRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkSzN|c5PDZpPkK0N|M4QDR4PD;hQi=>
H1975 NUT6TG9KSXCxcITvd4l{KEG|c3H5 MXyy{txO MVmyOIg> NYjHb416TE2VTx?= MljPbY5kemWjc3XzJIFxd3C2b4Ppd{Bz[XSnIIPp[45q\mmlYX70cJk> MmHpQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR|M{e4OFYoRjJ2M{O3PFQ3RC:jPh?=
BON NIGyTIdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4CzNlEuPc7:TR?= MYi3Nog> Ml2y[IVkemWjc3XzJINmdGxicILvcIln\XKjdHnvci=> MYS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDR2M{WyN{c,OjR2NEO1NlM9N2F-
BON NYnUOFRTSXCxcITvd4l{KEG|c3H5 M164WFEuPc7:TR?= NEjDbZMzPGh? NU\hZ4xUcW6lcnXhd4V{KGGyb4D0c5Nqew>? NELRclM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NES0N|UzOyd-MkS0OFM2OjN:L3G+
GBM M1G4SGFxd3C2b4Ppd{BCe3OjeR?= MUOy{txO MWK0PIg> M2D0fWROW09? MVjpcoR2[2WmIHjp[4hmeiCuZY\lcJMhd2ZiYYDvdJRwe2m|LDDhcoQh\GWlcnXhd4VlKGOnbHygeoli[mmuaYT5 MUG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDVyMES5Nkc,OjR3MEC0PVI9N2F-
FaDu MWPGeY5kfGmxbjDBd5NigQ>? M2LL[|Uh|ryP MX:yOEBp MofNSG1UVw>? NYXQN49zWmWmdXPld{BwgHmpZX6gZ49ve3WvcITpc44> NGfuOII9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NE[zNVE1Pyd-MkS2N|EyPDd:L3G+
EMT6 Mk[5SpVv[3Srb36gRZN{[Xl? NXjOW4JLPSEQvF2= M{jOclI1KGh? NUfFPXN2TE2VTx?= NWHlSpdrWmWmdXPld{BwgHmpZX6gZ49ve3WvcITpc44> MoLSQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR4M{GxOFcoRjJ2NkOxNVQ4RC:jPh?=
HCT116 NFn3WGtHfW6ldHnvckBCe3OjeR?= Ml70OUDPxE1? MViyOEBp MnzKSG1UVw>? NVnLTHhqWmWmdXPld{BwgHmpZX6gZ49ve3WvcITpc44> M1u2[FxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2NkOxNVQ4Lz5{NE[zNVE1PzxxYU6=
U87 MmTzSpVv[3Srb36gRZN{[Xl? M1\tbFUh|ryP NHjweYUzPCCq NUjKTpBtTE2VTx?= M3\POHJm\HWlZYOgc5h6\2WwIHPvcpN2dXC2aX;u Mm[0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR4M{GxOFcoRjJ2NkOxNVQ4RC:jPh?=
Saos-2 NYnGeWRQTnWwY4Tpc44hSXO|YYm= M2nLelUxKM7:TR?= NUXDTJdJPDhiaB?= MX\Jcohq[mm2czDj[YxtKGmwdnHzbY9v NFf1VVA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEeyO|Y3OCd-MkS3Nlc3PjB:L3G+
MG-63 NWDxeXhRTnWwY4Tpc44hSXO|YYm= MXu1NEDPxE1? NFvPOlI1QCCq M{TyPWlvcGmkaYTzJINmdGxiaX72ZZNqd25? MWS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDd{N{[2NEc,OjR5Mke2OlA9N2F-
SJSA-1 M4fGUGZ2dmO2aX;uJGF{e2G7 NGL5XlQ2OCEQvF2= MX20PEBp NGm1VZdKdmirYnn0d{Bk\WyuIHnueoF{cW:w NEDwPZY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEeyO|Y3OCd-MkS3Nlc3PjB:L3G+
Saos-2 MUDGeY5kfGmxbjDBd5NigQ>? NE\YeHU2OCEQvF2= NVT5RWlYPDhiaB?= MXXJcohq[mm2czDtZZRzcXhibXX0ZYxtd3C{b4TlbY5ie2VvMjDlfJBz\XO|aX;u M3fLS|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2N{K3OlYxLz5{NEeyO|Y3ODxxYU6=
MG-63 M2mzfGZ2dmO2aX;uJGF{e2G7 NFfUbVg2OCEQvF2= Mn;ROFghcA>? MV7Jcohq[mm2czDtZZRzcXhibXX0ZYxtd3C{b4TlbY5ie2VvMjDlfJBz\XO|aX;u M{PrVFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2N{K3OlYxLz5{NEeyO|Y3ODxxYU6=
SJSA-1 MYDGeY5kfGmxbjDBd5NigQ>? MmH6OVAh|ryP NYD4VllHPDhiaB?= M2nsemlvcGmkaYTzJI1ifHKreDDt[ZRidGyxcILveIVqdmG|ZT2yJIV5eHKnc4Ppc44> NXP5bI4xRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS3Nlc3PjBpPkK0O|I4PjZyPD;hQi=>
Saos-2 NHLlemVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVzPSFgxPTBizszN NX7XU21zPDhiaB?= MmniTY5pcWKrdIOgZ4VtdCC4aXHibYxqfHl? MX28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDd{N{[2NEc,OjR5Mke2OlA9N2F-
MG-63 M1XOPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M4WyS|UxKM7:TR?= NEDXdpY1QCCq M3PRUGlvcGmkaYTzJINmdGxidnnhZoltcXS7 MVu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDd{N{[2NEc,OjR5Mke2OlA9N2F-
SJSA-1 MmDLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUjqTXN1PTBizszN MmnnOFghcA>? NVLTPFBiUW6qaXLpeJMh[2WubDD2bYFjcWyrdIm= NFHiVnA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEeyO|Y3OCd-MkS3Nlc3PjB:L3G+
LN18 Mn7BS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGjGeXIzOCEQvF2= NFG5dFg4OiCq NFzUcWJFVVOR MoTCTWM2ODx3IN88US=> M{TBNVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2N{SxNFc1Lz5{NEe0NVA4PDxxYU6=
LN229 M37wb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnvJNlAh|ryP NGrmV5g4OiCq MlzvSG1UVw>? MX;JR|UxRDVizszN NGnS[4I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEe0NVA4PCd-MkS3OFExPzR:L3G+
LNZ308 MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NXXtZ2x2OjBizszN MX[3NkBp Mnn0SG1UVw>? M13mRWlEPTB:NTFOwG0> MmLBQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR5NEGwO|QoRjJ2N{SxNFc1RC:jPh?=
T98G NWXxcZA2T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFWwToczOCEQvF2= NGXyXYs4OiCq MVXEUXNQ MmfpTWM2ODx3IN88US=> NXGwTYNYRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS3OFExPzRpPkK0O|QyODd2PD;hQi=>
U87 NH\LfZNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFHNXoUzOCEQvF2= MoW2O|IhcA>? NGnjRo9FVVOR Mlr4TWM2ODx3IN88US=> MlLkQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR5NEGwO|QoRjJ2N{SxNFc1RC:jPh?=
LN18 MWLGeY5kfGmxbjDBd5NigQ>? NGnM[Yg2KM7:TR?= Mnq5NlQhcA>? M{HUXmROW09? NUW5OVJGUW6qaXLpeJMheGixc4Doc5J6dGG2aX;uJI9nKEGNVB?= NFLO[nU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEe0NVA4PCd-MkS3OFExPzR:L3G+
LNZ308 NULyN4E1TnWwY4Tpc44hSXO|YYm= NHrRWJg2KM7:TR?= NIqwUWIzPCCq Mm\QSG1UVw>? NH3rW5JKdmirYnn0d{BxcG:|cHjvdplt[XSrb36gc4YhSUuW Mkm2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR5NEGwO|QoRjJ2N{SxNFc1RC:jPh?=
MDA-MB-175 M4jtWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXixJO69VQ>? MXO1JIQ> MkjZSG1UVw>? MmfjTWM2ODxzIN88US=> NVrXVmtSRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS4O|k4QTZpPkK0PFc6Pzl4PD;hQi=>
MDA-MB-134 NHv3fo5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MmPWNUDPxE1? M1;MXlUh\A>? MnrBSG1UVw>? NEWzdGNKSzVyPEGg{txO MmfmQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR6N{m3PVYoRjJ2OEe5O|k3RC:jPh?=
HCC1500 NHjPeY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NFGxRlMyKM7:TR?= M1rHbVUh\A>? NF7qWIhFVVOR M1niRWlEPTB:MTFOwG0> M4nFUlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OEe5O|k3Lz5{NEi3PVc6PjxxYU6=
EFM-19 NF7SPVhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M3zjWlEh|ryP NED5SJk2KGR? Ml63SG1UVw>? M{jhV2lEPTB:MTFOwG0> NF3JWJQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEi3PVc6Pid-MkS4O|k4QTZ:L3G+
ZR-75-30 NFr0bIpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Ml20NUDPxE1? NF\6OI82KGR? NIHIeGhFVVOR MUDJR|UxRDFizszN NF\yTpM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEi3PVc6Pid-MkS4O|k4QTZ:L3G+
MDA-MB-361 MljkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWWxJO69VQ>? MXW1JIQ> M1i1W2ROW09? MlnjTWM2ODxzIN88US=> MX68ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDh5OUe5Okc,OjR6N{m3PVY9N2F-
T-47D MnvHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3P6W|Eh|ryP NH;aT2g2KGR? M1PMXmROW09? NYjBdHhuUUN3MEyxJO69VQ>? MkTVQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR6N{m3PVYoRjJ2OEe5O|k3RC:jPh?=
SK-BR-3 NUnSSlY6T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVexJO69VQ>? MorlOUBl NHjhRW5FVVOR MmL5TWM2ODxzIN88US=> NYqzTYxiRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS4O|k4QTZpPkK0PFc6Pzl4PD;hQi=>
UACC-732 M3zJXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M13sNFEh|ryP NIXaOY02KGR? M1zLdGROW09? Mn;ZTWM2ODxzIN88US=> NYTm[ZJxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS4O|k4QTZpPkK0PFc6Pzl4PD;hQi=>
BT-474 MmX2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYL0cHBYOSEQvF2= NEjvTJc2KGR? NHPUdFhFVVOR NX;NfZJ{UUN3MEyxJO69VQ>? NFrZZYE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEi3PVc6Pid-MkS4O|k4QTZ:L3G+
HCC202 MlfES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MWGxJO69VQ>? M{nQUFUh\A>? M1TZUmROW09? M{TBSmlEPTB:MTFOwG0> MojlQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR6N{m3PVYoRjJ2OEe5O|k3RC:jPh?=
MCF7 MljsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NHvmfYEyKM7:TR?= NWXYbWxFPSCm Ml;1SG1UVw>? MVXJR|UxRDFizszN Mn:0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR6N{m3PVYoRjJ2OEe5O|k3RC:jPh?=
MDA-MB-415 NHT3TI1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M{XWOFEh|ryP M4P6XVUh\A>? M2KxbmROW09? M4DPdGlEPTB:MTFOwG0> Ml;pQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR6N{m3PVYoRjJ2OEe5O|k3RC:jPh?=
MDA-MB-453 NV;zS5JHT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVfBOmtZOSEQvF2= MkLaOUBl NFjuTWlFVVOR NVuzdYlZUUN3MEyxJO69VQ>? NFrEPYw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEi3PVc6Pid-MkS4O|k4QTZ:L3G+
ZR-75-1 NYryeWNxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NH\xb|AyKM7:TR?= Mor1OUBl M2HMTGROW09? MljwTWM2ODxzIN88US=> MUO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDh5OUe5Okc,OjR6N{m3PVY9N2F-
HCC38 MlP2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MlvyNUDPxE1? MleyOUBl MlvoSG1UVw>? NHrHU2JKSzVyPEGg{txO MV28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDh5OUe5Okc,OjR6N{m3PVY9N2F-
HCC1419 Mn32S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MkK4NUDPxE1? NE\GWXU2KGR? MoW0SG1UVw>? MlLtTWM2ODxzIN88US=> MUS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDh5OUe5Okc,OjR6N{m3PVY9N2F-
UACC-812 M13He2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MWCxJO69VQ>? NH\tV4o2KGR? MUjEUXNQ MnPwTWM2ODxzIN88US=> NIjPdWM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEi3PVc6Pid-MkS4O|k4QTZ:L3G+
HCC1187 MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NV6zUFJnOSEQvF2= NF7qcGE2KGR? M1zEPWROW09? M4fCe2lEPTB:MTFOwG0> NGPET4Y9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEi3PVc6Pid-MkS4O|k4QTZ:L3G+
KPL-1 M4XMOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXXxTVNoOSEQvF2= NV\ZcHd1PSCm M{Dq[WROW09? Mnj3TWM2ODxzIN88US=> MVq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDh5OUe5Okc,OjR6N{m3PVY9N2F-
SUM-225 NFjYSHBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M4DsUlEh|ryP NX3JXIlmPSCm MlXPSG1UVw>? Ml61TWM2ODxzIN88US=> Mn7qQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR6N{m3PVYoRjJ2OEe5O|k3RC:jPh?=
EFM-192A NWTRPW86T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWD3R3FbOSEQvF2= NYDsTYZLPSCm MW\EUXNQ NFPOdIRKSzVyPEGg{txO MlvXQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR6N{m3PVYoRjJ2OEe5O|k3RC:jPh?=
JIMT-1 NYf1b|N[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MVuxJO69VQ>? NW[ycYRUPSCm MlTYSG1UVw>? MkTxTWM2ODxzIN88US=> MVW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDh5OUe5Okc,OjR6N{m3PVY9N2F-
HCC1143 NXHQbWc{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1TDSVEh|ryP MXO1JIQ> NEP4TnhFVVOR NFTVW4JKSzVyPEGg{txO M3rFXFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OEe5O|k3Lz5{NEi3PVc6PjxxYU6=
HCC2218 M1m5WGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NWLNNnRDOSEQvF2= MWO1JIQ> NYX5NoViTE2VTx?= NGmxTZlKSzVyPEGg{txO Mn\sQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR6N{m3PVYoRjJ2OEe5O|k3RC:jPh?=
MDA-MB-468 NITBXlFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NF\UbZEyKM7:TR?= NInHUXY2KGR? MVXEUXNQ NYniVY9KUUN3MEyxJO69VQ>? NV7DeFU2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS4O|k4QTZpPkK0PFc6Pzl4PD;hQi=>
BT-20 MnPMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MVyxJO69VQ>? MYO1JIQ> NHztbGRFVVOR NGTIW2FKSzVyPEGg{txO M3XRRlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OEe5O|k3Lz5{NEi3PVc6PjxxYU6=
MDA-MB-435 M1KxPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYnNbVF2OSEQvF2= M3PVNVUh\A>? MnnZSG1UVw>? M3\COWlEPTB:MTFOwG0> M3TNSFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OEe5O|k3Lz5{NEi3PVc6PjxxYU6=
BT-549 NUPEV5lXT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGTEUIIyKM7:TR?= NYr0OFFZPSCm MWPEUXNQ M{PRUGlEPTB:MTFOwG0> NI\ac|U9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEi3PVc6Pid-MkS4O|k4QTZ:L3G+
HCC1806 NH3TXmFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M13ocFEh|ryP NH64RpA2KGR? MW\EUXNQ MXfJR|UxRDFizszN MnTVQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR6N{m3PVYoRjJ2OEe5O|k3RC:jPh?=
HCC1937 Mlu3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NVLQZoNYOSEQvF2= NVv0O3NiPSCm M3KxO2ROW09? MnTqTWM2ODxzIN88US=> NHO0RlY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEi3PVc6Pid-MkS4O|k4QTZ:L3G+
Hs578T NVS2cpRoT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NGnLc2EyKM7:TR?= MnzVOUBl M2HMe2ROW09? M4jq[mlEPTB:MTFOwG0> M2Ww[VxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OEe5O|k3Lz5{NEi3PVc6PjxxYU6=
MCF7 NHLSRYREgXSxdH;4bYMhSXO|YYm= NWTiXFdmPzJiaB?= MX;EUXNQ NEPDU5hEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBOS0Z5IHPlcIx{KGW6cILld5NqdmdiUFmzT4FteGijIFW1OFVMKG23dHHueEB4cXSqIFfJOVAhd2ZiMD6wNFAyPThizszN M1j6dVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OUCwNlY3Lz5{NEmwNFI3PjxxYU6=
DU145 NFPQO|hEgXSxdH;4bYMhSXO|YYm= Mn7qO|IhcA>? M4P6fWROW09? M4S1TGN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGRWOTR3IHPlcIx{KGW6cILld5NqdmdiTFvCNUBufXSjboSge4l1cCCJSUWwJI9nKDBwMECwOFM2KM7:TR?= NEHNe4I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEmwNFI3Pid-MkS5NFAzPjZ:L3G+
A2780 NYq5W5hES3m2b4TvfIlkKEG|c3H5 MlzHO|IhcA>? MUXEUXNQ M{nPdWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KFCWRV6t[IVncWOrZX70JIh2dWGwIFGyO|gxKGOnbHzzJJdqfGhiR1m1NEBw\iByLkCwNFY{PSEQvF2= NXrjcnI1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS5NFAzPjZpPkK0PVAxOjZ4PD;hQi=>
U87MG M2rRfGN6fG:2b4jpZ{BCe3OjeR?= MX:3NkBp NGTDeWNFVVOR MoPOR5l1d3SxeHnjbZR6KGGpYXnud5QhWFSHTj3k[YZq[2mnboSgbJVu[W5iVUi3UWch[2WubIOge4l1cCCJSUWwJI9nKDBwMECwOlk5KM7:TR?= M4\GflxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OUCwNlY3Lz5{NEmwNFI3PjxxYU6=
A2780 NVrBemlITnWwY4Tpc44hSXO|YYm= NEDJNGoyKGh? MXvEUXNQ MYXJcohq[mm2aX;uJI9nKFCLM1utcYVlcWG2ZXSgRWtVKFOnckS3N{BxcG:|cHjvdplt[XSrb36ge4l1cCCHQ{WwJI9nKDBwMEW1JO69VQ>? MXi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDlyMEK2Okc,OjR7MECyOlY9N2F-
DU145 NWnrWYlSTnWwY4Tpc44hSXO|YYm= MWexJIg> M2nn[GROW09? M{nFOmlvcGmkaYTpc44hd2ZiUFmzT{1u\WSrYYTl[EBCU1RiU3XyOFc{KHCqb4PwbI9zgWyjdHnvckBqdiCqdX3hckBFXTF2NTDj[YxteyCqYYLic5JqdmdiTFvCNUBufXSjdHnvckB4cXSqIFXDOVAhd2ZiMD6wO|Mh|ryP NXj4VY5XRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS5NFAzPjZpPkK0PVAxOjZ4PD;hQi=>
A2780 NFzIXVZHfW6ldHnvckBCe3OjeR?= Ml7nNUBp MmXVSG1UVw>? MUTJcohq[mm2aX;uJI9nKFCLM1utcYVlcWG2ZXSgRWtVKFOnckS3N{BxcG:|cHjvdplt[XSrb36gbY4hWFSHTj3k[YZq[2mnboSgbJVu[W5iQUK3PFAh[2WubIOge4l1cCCHQ{WwJI9nKDBwMEe0JO69VQ>? NUTBZ4t7RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS5NFAzPjZpPkK0PVAxOjZ4PD;hQi=>
MCF7 NFfEbppHfW6ldHnvckBCe3OjeR?= MYexJIg> NWDRPXNjTE2VTx?= MUXJcohq[mm2aX;uJI9nKFCLM1vhcJBp[SCHNUS1T{BufXSjboStcYVlcWG2ZXSgRWtVKFOnckS3N{BxcG:|cHjvdplt[XSrb36ge4l1cCCHQ{WwJI9nKDBwMTFOwG0> MWC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDlyMEK2Okc,OjR7MECyOlY9N2F-
U87MG MY\GeY5kfGmxbjDBd5NigQ>? MoPmNUBp MnLLSG1UVw>? NVnwcVBjUW6qaXLpeIlwdiCxZjDQTVNMNW2nZHnheIVlKEGNVDDT[ZI1PzNicHjvd5Bpd3K7bHH0bY9vKGmwIGDUSW4u\GWoaXPp[Y51KGi3bXHuJHU5P02JIHPlcIx{KHerdHigSWM2OCCxZjCwMlE{KM7:TR?= NH7v[lU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEmwNFI3Pid-MkS5NFAzPjZ:L3G+
A2780 MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MX[3NkBp Mn;zSG1UVw>? NWLze4pOTUN3ME2wMlUzKM7:TR?= NHXzZXE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEmwNFI3Pid-MkS5NFAzPjZ:L3G+
Huh7 NUTId4NiTnWwY4Tpc44hSXO|YYm= NFL3OIYyKM7:TR?= Mn\xNUBp MXPEUXNQ NHPPW5VKdmirYnn0d{BxcG:|cHjvdplt[XSrb36gc4YhSUuWIHH0JHNmejR5NB?= NUXuW|JRRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWwNFQ1ODNpPkK1NFA1PDB|PD;hQi=>
BNL NIPlfW5HfW6ldHnvckBCe3OjeR?= MUWxJO69VQ>? Mm\ENUBp M1GwVmROW09? MlfKTY5pcWKrdIOgdIhwe3Cqb4L5cIF1cW:wIH;mJHM3 MYS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTByNESwN{c,OjVyMES0NFM9N2F-
BON-1 NXnzSW1ST3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4XnblUxOCCwTR?= NGm0XWcyOCCm NVLuN2NZTE2VTx?= MkO3TY5pcWKrdIOgZ4VtdCCpcn;3eIg> MYC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTB{NkK5Nkc,OjVyMk[yPVI9N2F-
BON-1 NIHacFNHfW6ldHnvckBCe3OjeR?= NUTNR4ROPTByIH7N MWq0JIg> M4fDfGROW09? M4XkTmlvcGmkaYTzJJBpd3OyaH;yfYxifGmxbjDv[kBCU1RiYYSgWIhzOzB6IHHu[EBU\XJ2N{O= NE\vUIg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUCyOlI6Oid-MkWwNlYzQTJ:L3G+
QGP-1 M4q3U2Z2dmO2aX;uJGF{e2G7 NX3PXXpMPTByIH7N NYPuOXhGPCCq NGXIblRFVVOR MoToTY5pcWKrdIOgdIhwe3Cqb4L5cIF1cW:wIH;mJGFMXCCjdDDUbJI{ODhiYX7kJHNmejR5Mx?= MmfkQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjVyMk[yPVIoRjJ3MEK2NlkzRC:jPh?=
HCT-15 NEfVT3NCeG:2b4Ppd{BCe3OjeR?= NVf4bFBJOTBizszN NGXFUm01QCCq MWrEUXNQ NIfVOHZKdmS3Y3XzJIFxd3C2b4Ppd{BqdiCKQ2StNVUh[2WubIOgbIFz[m:3cnnu[{BRUUt|Q1GgbI91e3CxdDDteZRifGmxbh?= MVi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTF3MkK0OUc,OjVzNUKyOFU9N2F-
HCT-116 M3fIc2Fxd3Sxc3nzJGF{e2G7 NI[zb4YyOCEQvF2= Mlq3OFghcA>? M2TmUmROW09? Ml31TY5lfWOnczDhdI9xfG:|aYOgbY4hUEOWLUGxOkBk\WyuczDoZZJjd3W{aX7nJHBKUzOFQTDoc5R{eG:2IH31eIF1cW:w NGTGN5U9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUG1NlI1PSd-MkWxOVIzPDV:L3G+
NCI-H460 M4WzfWFxd3Sxc3nzJGF{e2G7 NFfvT4cyOCEQvF2= Mmr5OFghcA>? NUXGZ5loTE2VTx?= NV;ZTlhDUW6mdXPld{BieG:ydH;zbZMhcW5iTlPJMWg1PjBiY3XscJMhcGG{Yn;1dolv\yCSSVuzR2EhcG:2c4DveEBufXSjdHnvci=> M1;WN|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3MUWyNlQ2Lz5{NUG1NlI1PTxxYU6=
SKOV-3 NGTU[npCeG:2b4Ppd{BCe3OjeR?= M2TpSlExKM7:TR?= M3z6bFQ5KGh? M3HDbWROW09? MmTaTY5lfWOnczDhdI9xfG:|aYOgbY4hW0uRVj2zJINmdGy|IHjhdoJwfXKrbnegVGlMO0ODIHjveJNxd3RibYX0ZZRqd25? MVe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTF3MkK0OUc,OjVzNUKyOFU9N2F-
BSY-1 NGXlcZBCeG:2b4Ppd{BCe3OjeR?= NGHlXmUyOCEQvF2= NIOwRlA1QCCq M4PuNWROW09? NVvzRphvUW6mdXPld{BieG:ydH;zbZMhcW5iQmPZMVEh[2WubIOgbIFz[m:3cnnu[{BRUUt|Q1GgbI91e3CxdDDteZRifGmxbh?= NWHWR|A4RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWxOVIzPDVpPkK1NVUzOjR3PD;hQi=>
MKN-1 NITiPIpCeG:2b4Ppd{BCe3OjeR?= MVixNEDPxE1? M1i0cVQ5KGh? MoPjSG1UVw>? NIHMdYhKdmS3Y3XzJIFxd3C2b4Ppd{BqdiCPS16tNUBk\WyuczDoZZJjd3W{aX7nJHBKUzOFQTDoc5R{eG:2IH31eIF1cW:w MUC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTF3MkK0OUc,OjVzNUKyOFU9N2F-
NCI-H522 NFG1[W9CeG:2b4Ppd{BCe3OjeR?= M3rYeFExKM7:TR?= NVrWNYlEPDhiaB?= Ml7RSG1UVw>? MYPJcoR2[2W|IHHwc5B1d3Orcx?= NGn6ZWc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUG1NlI1PSd-MkWxOVIzPDV:L3G+
OVCAR-3 NH\ZZotCeG:2b4Ppd{BCe3OjeR?= M2\0eVExKM7:TR?= NYXOe4tNPDhiaB?= NHnyXXBFVVOR Mmi0TY5lfWOnczDhdI9xfG:|aYO= NVvF[|VZRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWxOVIzPDVpPkK1NVUzOjR3PD;hQi=>
HBC-5 M1XxUGFxd3Sxc3nzJGF{e2G7 MkfLNVAh|ryP NYr6S|VIPDhiaB?= MXXEUXNQ Ml[5TY5lfWOnczDhdI9xfG:|aYO= NXWwcJhORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWxOVIzPDVpPkK1NVUzOjR3PD;hQi=>
RXF-631L M2PtRmFxd3Sxc3nzJGF{e2G7 MWGxNEDPxE1? MW[0PEBp MUDEUXNQ M2DITmlv\HWlZYOgZZBweHSxc3nz MnO1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjVzNUKyOFUoRjJ3MUWyNlQ2RC:jPh?=
MKN-45 NUC2VFFUSXCxdH;zbZMhSXO|YYm= NF;ZeFcyOCEQvF2= MVm0PEBp NXjpWJR7TE2VTx?= M1LVfGlv\HWlZYOgZZBweHSxc3nz NInTSWs9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUG1NlI1PSd-MkWxOVIzPDV:L3G+
LNCaP M{\ObGZ2dmO2aX;uJGF{e2G7 Ml\0NUDPxE1? M13ZT3N2eHC{ZYPz[ZMheC2DS2SgcIV3\Wy| MYq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTN4MEe5PUc,OjV|NkC3PVk9N2F-
LNCaP95 MWDGeY5kfGmxbjDBd5NigQ>? MnTSNUDPxE1? M2e2eXN2eHC{ZYPz[ZMheC2DS2SgcIV3\Wy| MXK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTN4MEe5PUc,OjV|NkC3PVk9N2F-
A549 NWLsWlRVTnWwY4Tpc44hSXO|YYm= MYi1NFAhdk1? NWrBSHNnPDhiaB?= MYPEUXNQ NUj1T4JMUW6qaXLpeJMhSWu2IHHjeIl3[XSrb36= M1XwNVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3OUO3Nlk6Lz5{NUmzO|I6QTxxYU6=
A549 NVvDN4l{T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4e3clEh|ryP NXT6dYU5PzJiaB?= NYPWeGhETE2VTx?= NHHkZmRKdmirYnn0d{Bk\WyuIHfyc5d1cA>? MXe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTl|N{K5PUc,OjV7M{eyPVk9N2F-
H522 NUDIO2F1T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MmXENUDPxE1? MUS3NkBp MVTEUXNQ MXLJcohq[mm2czDj[YxtKGe{b4f0bC=> Mn\jQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV7M{eyPVkoRjJ3OUO3Nlk6RC:jPh?=
SKMES-1 MmrlR5l1d3SxeHnjJGF{e2G7 NGO4XXkyKM7:TR?= NVXGXG45PzJiaB?= M1rGRWlv\HWlZYOgZ4VtdCCmZXH0bC=> NIfLOWc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NkCxN|MyQCd-Mk[wNVM{OTh:L3G+
H596 M2L3N2Z2dmO2aX;uJGF{e2G7 Mn7JNUDPxE1? NX3hPWN[UW2yYXnyd{Bk\WyuIH3p[5JifGmxbh?= MYm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPjBzM{OxPEc,OjZyMUOzNVg9N2F-
HCC2450 M1r4XWZ2dmO2aX;uJGF{e2G7 MkLmNUDPxE1? MVTJcZBicXK|IHPlcIwhcW64YYPpc44> MWm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPjBzM{OxPEc,OjZyMUOzNVg9N2F-
HCT116 NHjMWHdCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= M3fFVFczKGi{cx?= NGTlenNCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFjDWFEyPiClZXzsd{Bi\nSncjC3NkBpenNiYomgUXRVKGG|c3H5MEBKSzVyIE2gNE41QCEQvF2u M4fjdFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3N{[1PVA6Lz5{NUe2OVkxQTxxYU6=
MCF7 NWPUUVA3SW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= MWi3NkBpenN? NVTaO5Y6SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDNR2Y4KGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDNWHQh[XO|YYmsJGlEPTBiPTCxJO69VS5? M1HQN|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3N{[1PVA6Lz5{NUe2OVkxQTxxYU6=
U87MG Mk\ERY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? MnzHO|IhcHK| NUe3eXFTSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDVPFdOTyClZXzsd{Bi\nSncjC3NkBpenNiYomgUXRVKGG|c3H5MEBKSzVyIE2gNU43PCEQvF2u MXW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTd4NUmwPUc,OjV5NkW5NFk9N2F-
A549 M3i3OGFvfGmycn;sbYZmemG2aY\lJIF{e2G7 NVvQbWRYPzJiaILz NFjVWWdCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFG1OFkh[2WubIOgZYZ1\XJiN{KgbJJ{KGK7IF3UWEBie3OjeTygTWM2OCB;IEKuNFch|ryPLh?= M3PsN|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3N{[1PVA6Lz5{NUe2OVkxQTxxYU6=
HeLa NG\1b2dCdnSrcILvcIln\XKjdHn2[UBie3OjeR?= M2\oOlczKGi{cx?= NYHsfY97SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDI[WxiKGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDNWHQh[XO|YYmsJGlEPTBiPTC0MlM1KM7:TT6= M{jjflxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3N{[1PVA6Lz5{NUe2OVkxQTxxYU6=
HCT116 MYLGeY5kfGmxbjDhd5NigQ>? MofaNVAhfU1? M1zpelEhcHJ? MkLiTY5pcWKrdHnvckBw\iCSSUPLM2FsfCCrbjDoeY1idiCKQ2SxNVYh[2WubIOgZZN{\XO|ZXSgZZMhSWu2IIDoc5NxcG:{eXzheIlwdiCjdDCxNEB2VSCjZoTldkAyKGi{IHL5JHdme3Sncn6gZoxwfHSrbnegZY5idHm|aYO= NUHKOJg6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW3OlU6ODlpPkK1O|Y2QTB7PD;hQi=>
A2058 melanoma NYfKVm5HS2WubDDjfYNt\SCjc4PhfS=> MYK1JJVO M3zWZ|I1KGi{cx?= NH3uWFRE\WyuIHP5Z4xmKGG{cnXzeEBqdiCqdX3hckBCOjB3ODDt[Yxidm:vYTDj[YxteyCjc4Pld5Nm\CCjczDhZ4N2dXWuYYTpc44h[XRiU4XiS|EheGijc3WgZZQhPSC3TTDh[pRmeiB{NDDodpMh[nlicILvdIllcXWvIHnv[Ill\SC|dHHpcolv\yCkYYPl[EBHSUOVIHHuZYx6e2m| NY\X[lJFRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMki4Nlk2QTJpPkK4PFI6PTl{PD;hQi=>
A2058 melanoma NVnDTGdyS2WubDDjfYNt\SCjc4PhfS=> NWfjZ2NZPSC3TR?= NF7lZ4MzPCCqcoO= M{LIUWNmdGxiY4njcIUh[XK{ZYP0JIlvKGi3bXHuJGEzODV6IH3lcIFvd22jIHPlcIx{KGG|c3Xzd4VlKGG|IHHjZ5VufWyjdHnvckBifCCJMj;NJJBp[XOnIHH0JFUhfU1iYX\0[ZIhOjRiaILzJIJ6KHC{b4Dp[Il2dSCrb3Tp[IUhe3SjaX7pcoch[mG|ZXSgSmFEWyCjbnHsfZNqew>? NFizcZc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEiyPVU6Oid-Mki4Nlk2QTJ:L3G+
SKOV3 MoewR4VtdCCleXPs[UBie3OjeR?= MUWyJJVO M3jtUlI1KGi{cx?= NWfGcJp5S2WubDDjfYNt\SCjcoLld5QhcW5iaIXtZY4hW0uRVkOgZ4VtdHNiYYPz[ZN{\WRiYYOgZYNkfW23bHH0bY9vKGG2IFeyM20heGijc3WgZZQhOiC3TTDh[pRmeiB{NDDodpMh[nlicILvdIllcXWvIHnv[Ill\SC|dHHpcolv\yCkYYPl[EBHSUOVIHHuZYx6e2m| NIHpcIk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEiyPVU6Oid-Mki4Nlk2QTJ:L3G+
SKOV3 MkXlR4VtdCCleXPs[UBie3OjeR?= M4DYW|IhfU1? NYe0e3YxOjRiaILz NIPQV3ZE\WyuIHP5Z4xmKGG{cnXzeEBqdiCqdX3hckBUU0:YMzDj[YxteyCjc4Pld5Nm\CCjczDhZ4N2dXWuYYTpc44h[XRiU4XiS|EheGijc3WgZZQhOiC3TTDh[pRmeiB{NDDodpMh[nlicILvdIllcXWvIHnv[Ill\SC|dHHpcolv\yCkYYPl[EBHSUOVIHHuZYx6e2m| NEHGUpk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEiyPVU6Oid-Mki4Nlk2QTJ:L3G+
MDA-MB-231 NFLySnNEgXSxdH;4bYNqfHliYYPzZZk> NVzz[mtJPzJiaILz MVTDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDNSGEuVUJvMkOxJINmdGy|IHHmeIVzKDd{IHjyd{BjgSCPVGSgZZN{[XluIFnDOVAhRSBzLki4JO69VS5? NGruTFk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUGwO|QzQSd-MkmxNFc1Ojl:L3G+
PC3 MlSzR5l1d3SxeHnjbZR6KGG|c3H5 MljGO|IhcHK| NV;T[2pVS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hWEN|IHPlcIx{KGGodHXyJFczKGi{czDifUBOXFRiYYPzZZktKEmFNUCgQUA2NjN2IN88UU4> M3TxdVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7MUC3OFI6Lz5{OUGwO|QzQTxxYU6=
T47D MWXDfZRwfG:6aXPpeJkh[XO|YYm= NHPHTWY4OiCqcoO= NV;PWHUzS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hXDR5RDDj[YxteyCjZoTldkA4OiCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwJF0hPi57MjFOwG0v NFvFd3I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUGwO|QzQSd-MkmxNFc1Ojl:L3G+
MCF7 NGDweY5EgXSxdH;4bYNqfHliYYPzZZk> NFWycWE4OiCqcoO= M{H2WWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJG1ETjdiY3XscJMh[W[2ZYKgO|IhcHK|IHL5JG1VXCCjc4PhfUwhUUN3MDC9JFEyNjB3IN88UU4> NHnvT4U9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUGwO|QzQSd-MkmxNFc1Ojl:L3G+
TC32 MX\xTHRUKGG|c3H5 MX7xTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhXEN|MjDj[Yxtew>? MYG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
A673 M2G2V5FJXFNiYYPzZZk> Mn7JdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKEF4N{OgZ4VtdHN? MWe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
DAOY NV3FcHFMeUiWUzDhd5NigQ>? NYH2N5J7eUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IFTBU3kh[2WubIO= MXe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
Saos-2 NFvJNYxyUFSVIHHzd4F6 MkXadWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKFOjb4OtNkBk\Wyucx?= MVe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
BT-37 MmrLdWhVWyCjc4PhfS=> M3XFfZFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCEVD2zO{Bk\Wyucx?= Mle5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
RD NX7jS|k{eUiWUzDhd5NigQ>? NEHmNHdyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiUlSgZ4VtdHN? M3TyeFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
SK-N-SH MmXwdWhVWyCjc4PhfS=> M3S4SJFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCVSz3OMXNJKGOnbHzz Mme1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
BT-12 MkjTdWhVWyCjc4PhfS=> NID3dJdyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiQmStNVIh[2WubIO= NUjBdVlTRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
MG 63 (6-TG R) MoXHdWhVWyCjc4PhfS=> Mn3KdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKE2JIE[zJEg3NVSJIGKpJINmdGy| MWK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
NB1643 MV;xTHRUKGG|c3H5 NUnESIpqeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IF7CNVY1OyClZXzsdy=> MYi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
OHS-50 NYPYRXJEeUiWUzDhd5NigQ>? Mn3adWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKE:KUz21NEBk\Wyucx?= MXW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
SK-N-SH MV\xTHRUKGG|c3H5 M{DxV5FJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KEOxbn\pdo1ifG:{eTDzZ5Jm\W5iZn;yJHNMNU5vU1igZ4VtdHN? NFPEUZY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
Rh41 MXrxTHRUKGG|c3H5 MUfxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhWmh2MTDj[Yxtew>? NV3sUGxrRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
A673 M{PK[5FJXFNiYYPzZZk> MVHxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBEd26oaYLtZZRwenlic3Py[YVvKG[xcjDBOlc{KGOnbHzzLS=> NUHmc3k3RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
Rh30 MkD2dWhVWyCjc4PhfS=> NIDOdZpyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiUnizNEBk\Wyucx?= NV21NY5TRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
MG 63 (6-TG R) NF[4Om9yUFSVIHHzd4F6 MXvxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBEd26oaYLtZZRwenlic3Py[YVvKG[xcjDNS{A3OyBqNj3US{BTMSClZXzsdy=> M1XYTlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
Rh30 NF\HUoFyUFSVIHHzd4F6 NGG1cWNyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCFb37mbZJu[XSxcomgd4Nz\WWwIH\vdkBTcDNyIHPlcIx{ MYG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
U-2 OS MlvBdWhVWyCjc4PhfS=> NHr4UVRyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCFb37mbZJu[XSxcomgd4Nz\WWwIH\vdkBWNTJiT2OgZ4VtdHN? MlnSQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
Rh41 M3vjWpFJXFNiYYPzZZk> MoDwdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohS2:wZnnycYF1d3K7IIPjdoVmdiCob4KgVog1OSClZXzsdy=> MVu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
RD NGHlVYhyUFSVIHHzd4F6 NInQeHRyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCFb37mbZJu[XSxcomgd4Nz\WWwIH\vdkBTTCClZXzsdy=> M4nZ[lxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
SJ-GBM2 M4e0fZFJXFNiYYPzZZk> NVLtWpJjeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IGPKMWdDVTJiY3XscJM> MWq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
SK-N-MC MWTxTHRUKGG|c3H5 NIK4TVdyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiU1utUk1OSyClZXzsdy=> MlzWQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
NB-EBc1 NIC1cJFyUFSVIHHzd4F6 M1jIdpFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCQQj3FRoMyKGOnbHzz M{XpdVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
LAN-5 Mnf2dWhVWyCjc4PhfS=> M4HWdpFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCOQV6tOUBk\Wyucx?= M3zMRVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
Rh18 Mlm0dWhVWyCjc4PhfS=> Mnz3dWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKFKqMUigZ4VtdHN? NFfDe4c9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
SK-N-MC NWfYUFFVeUiWUzDhd5NigQ>? NH[zTnJyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCFb37mbZJu[XSxcomgd4Nz\WWwIH\vdkBUUy2QLV3DJINmdGy| M4PlcVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
TC32 MYLxTHRUKGG|c3H5 Mn7odWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohS2:wZnnycYF1d3K7IIPjdoVmdiCob4KgWGM{OiClZXzsdy=> MW[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
insect M4\JdmZ2dmO2aX;uJIF{e2G7 NWf6UHo6UW6qaXLpeIlwdiCxZjDy[YNwdWKrbnHueEBpfW2jbjDIbZMufGGpZ3XkJJA5PWGucHjhM5AyOTCjbIDoZUBGPTR3SzDteZRidnRiZYjwdoV{e2WmIHnuJIlve2WldDDj[YxteyxiSVO1NEA:KDBwMEGxJO69VS5? MWi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{ODB|NE[wO{c,OzByM{S2NFc9N2F-
insect MmPOSpVv[3Srb36gZZN{[Xl? MnvKTY5pcWKrdHnvckBw\iC{ZXPvcYJqdmGwdDDoeY1idiCKaYOteIFo\2WmIIC4OYFteGijL4CxNVBidHCqYTDFOVQzUyCvdYThcpQh\XiycnXzd4VlKGmwIHnud4VkfCClZXzsd{whUUN3MDC9JFAvODJ7IN88UU4> NEnLepI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9|MECzOFYxPyd-M{CwN|Q3ODd:L3G+
Sf21 MVLGeY5kfGmxbjDhd5NigQ>? MnvINUBpeg>? MYfJcohq[mm2aX;uJI9nKHKnY3;tZolv[W62IHj1cYFvKG[3bHytcIVv\3SqIF6teIVzdWmwYXygTIl{Pi22YXfn[YQheDFzMHTlcJRiN3KnY3;tZolv[W62IHj1cYFvKG[3bHygcIVv\3SqIIC4OYFteGijIHX4dJJme3OnZDDpckBj[WO3bH;2bZJ2eyCrbn\lZ5Rm\CCVZkKxJIlve2WldDDj[YxteyC3c3nu[{BRUVB{IHHzJJN2[nO2cnH0[UBu\WG|dYLl[EBi\nSncjCxJIhzKGK7IFHs[ZhiPjN|IGTyZYNmei2kYYPl[EBndHWxcnXzZ4Vv[2VicH;sZZItKEmFNUCgQUAxNjF{NTFOwG0v NFvSO3I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9|MECzOFYxPyd-M{CwN|Q3ODd:L3G+
MCF7 MV;BcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? NWLvW4VLPzJiaILz NXu3fY1LSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDNR2Y4KGOnbHzzJIhiemKxcnnu[{BRUUt|Q1GgSVU1PUtibYX0ZY51KGGodHXyJFczKGi{czDifUBOXFRiYYPzZZktKEmFNUCgQUAxNjJyNjFOwG0v MUW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8{ODB|NE[wO{c,OzByM{S2NFc9N2F-
Sf21 M2DUU2Z2dmO2aX;uJIF{e2G7 MojsNUBpeg>? MmrXTY5pcWKrdHnvckBw\iC{ZXPvcYJqdmGwdDDoeY1idiCodXzsMYxmdme2aDDOMZRmem2rbnHsJGhqezZvdHHn[4VlKHBzMUDi[ZRiN3KnY3;tZolv[W62IHj1cYFvKG[3bHygcIVv\3SqIIC4OYFteGijIHX4dJJme3OnZDDpckBj[WO3bH;2bZJ2eyCrbn\lZ5Rm\CCVZkKxJIlve2WldDDj[YxteyC3c3nu[{BRUVB{IHHzJJN2[nO2cnH0[UBu\WG|dYLl[EBi\nSncjCxJIhzKGK7IFHs[ZhiPjN|IGTyZYNmei2kYYPl[EBndHWxcnXzZ4Vv[2VicH;sZZJqNCCLQ{WwJF0hOC5{M{Sg{txONg>? M3nOUFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzNyMEO0OlA4Lz5|MECzOFYxPzxxYU6=
T47D NWr5dVlwSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= NInjSpY4OiCqcoO= M4KwUWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iVES3SEBk\WyuczDoZZJjd3KrbnegVGk{U0ODIFixNFQ4WiCvdYThcpQh[W[2ZYKgO|IhcHK|IHL5JG1VXCCjc4PhfUwhUUN3MDC9JFAvOjh4IN88UU4> NI\XN4M9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9|MECzOFYxPyd-M{CwN|Q3ODd:L3G+
PC3 Mk[4SpVv[3Srb36gZZN{[Xl? MlTBNkBpenN? Ml;4TY5pcWKrdHnvckBw\iCSSUPLJIlvKGi3bXHuJHBEOyClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6gRWtVKHCqb4PwbI9zgWyjdHnvckBifCCVZYK0O|MhdWWjc4Xy[YQh[W[2ZYKgNkBpenNiYomg[ox2d3Knc3PlcoNmKGG|c3H5MEBKSzVyIE2gNE4{PjVizszNMi=> M1WyTVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzNyMEO0OlA4Lz5|MECzOFYxPzxxYU6=
HT-29 NUXJOlVPS2WubDDjfYNt\SCjc4PhfS=> M4jGclAvOTFzIITvJFMhfU1? NVzVV2VFOjRiaILz M4fQeGNmdGxiY4njcIUh[XK{ZYP0JIlvKGi3bXHuJGhVNTJ7IHPlcIx{KGG|c3Xzd4VlKGG|IHHjZ5VufWyjdHnvckBifCCJMj;NJJBp[XOnIHH0JFAvOTFzIITvJFMhfU1iYX\0[ZIhOjRiaILzJIJ6KHC{b4Dp[Il2dSCrb3Tp[IUhe3SjaX7pcoch[mG|ZXSg[oxwfyCleYTvcYV1enl? NWP0dG06RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxM{CwN|Q3ODdpPkOwNFM1PjB5PD;hQi=>
A2058 MorTSpVv[3Srb36gZZN{[Xl? M2\YXVEhcHJ? MXPJcohq[mm2aX;uJI9nKFSRUlOyJIlvKGi3bXHuJGEzODV6IHPlcIx{KGG|c3Xzd4VlKGG|IHTlZ5Jm[XOnIHnuJHBMSi:Da4SgdIhwe3Cqb4L5cIF1cW:wIHH0JHNmejR5MzDh[pRmeiBzIHjyJIJ6KFenc4Tldo4h[myxdDDhcoFtgXOrczygTWM2OCB;IECuOFE3KM7:TT6= NFvHSGc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9|MEO1PVAxOyd-M{CzOVkxODN:L3G+
A2058 MkLJSpVv[3Srb36gZZN{[Xl? NXHOTZc4OSCqch?= NEPrSHhKdmirYnn0bY9vKG:oIGTPVmMyKGmwIHj1cYFvKEF{MEW4JINmdGy|IHHzd4V{e2WmIHHzJIRm[3KnYYPlJIlvKFN4IIDoc5NxcG:{eXzheIlwdiCjdDDT[ZIzOzVxMkO2JIFnfGW{IEGgbJIh[nliV3XzeIVzdiCkbH;0JIFv[Wy7c3nzMEBKSzVyIE2gNE42PTNizszNMi=> NX\5bWlDRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxM{CzOVkxODNpPkOwN|U6ODB|PD;hQi=>

... Click to View More Cell Line Experimental Data

Assay
Methods Test Index PMID
Western blot
p-AKT (T308) / p-AKT (S473) / AKT; 

PubMed: 27283525     


Left western blots showing levels of pAkt (T308), pAkt (S473) and total Akt in U87 cells exposed to buparlisib for 72 h. Right densitometric assessment of western blots, showing relative changes in phosphorylation.

p-FOXO3a (S253) / FOXO3a; 

PubMed: 28036259     


Cells were treated with 0.5 μM BKM120 for 24 h and cell lysates were immunoblotted with the indicated antibodies. Actin was used as the loading control.

Nuclear NF-κB p65 / NF-κB p65; 

PubMed: 26673665     


Western blots show BKM120 downregulating pAKT, nuclear NF-κB p65 and total NF-κB p65 in MDR and their parental cells. β-actin was used as a loading control for pAKT, AKT and total NF-κB p65. Lamin B was used as a loading control for nuclear NF-κB p65. 

p-ERK / ERK / LC3; 

PubMed: 27572309     


The indicated cell lines were exposed to different concentrations of BKM120 as indicated for 8 h A. or with 2 μM BKM120 for the indicated times B. The cells were then harvested for preparation of whole-cell protein lysates and subsequent Western blot analysis to detect the given proteins.

p-STAT3 / STAT3 / p-ERK / ERK / p-S6; 

PubMed: 29928341     


Western blot analysis of H460 and H2126 cell lysates using specific antibodies to phosphorylated or total proteins of STAT3, ERK1/2, AKT, S6 or GAPDH (loading control). The cells were treated with increasing concentrations of BKM120 for 24 h.

p-MET / MET; 

PubMed: 29928341     


The expression of phosphorylated or total forms of MET protein was analyzed by western blotting. 

27283525 28036259 26673665 27572309 29928341
Immunofluorescence
FOXO3a; 

PubMed: 28036259     


Cells were cultured on coverslips to approximately 60% confluency and then treated with 1 μM BKM120 for an additional 24 h. Immunofluorescence staining was performed using an anti-FOXO3a antibody and the nuclei were stained with DAPI. Scale bar, 20 μm.

28036259
Growth inhibition assay
Cell viability; 

PubMed: 26673665     


Dose-response curves were used to calculate the IC50 of BKM120 for MCs of MCF-7/A02 cells (upper) and CALDOX cells (lower).

26673665
体内研究 BKM120按30, 60, 或100 mg/kg剂量作用于A2780移植瘤,完全抑制pAKTser473。BKM120按 30和 60 mg/kg剂量作用于U87MG神经胶质瘤模型,显示抗癌活性。[1]BKM120每天按5μM/kg剂量处理具有持久生命力的ARP1 SCID鼠模型,导致肿瘤体积和K链水平明显降低。[2]

推荐的实验操作(此推荐来自于公开的文献所以Selleck并不保证其有效性)

激酶实验:[2]
- 合并

PI3K 生化实验(ATP 消耗实验):

BKM120溶于DMSO中,按每孔1.25 µL直接加到黑色384孔板上。开始反应, 25 µL 10nM PI3K和5 µg/mL 1-α-磷酸肌醇(PI)加到实验 buffer (10 mM Tris pH 为7.5, 5 mM MgCl2, 20 mM NaCl, 1 mM DTT,及0.05% CHAPS),然后加到每孔中,随后在实验buffer中加入25 µL 2 µM ATP。反应进行直到50% ATP被消耗,然后加入25 µL KinaseGlo溶液终止反应。终止的反应温育5分钟,然后通过荧光测定残留的ATP。
细胞实验:[1]
- 合并
  • Cell lines: A2780细 胞
  • Concentrations: 0-6.6 μM
  • Incubation Time: 3天
  • Method: A2780细胞培养在含10% FBS,L-谷氨酸,丙酮酸钠和抗生素的DMEM培养基上。细胞按每孔103个细胞的密度接种在相同培养基上,温育3到5小时。稀释溶于20 mM DMSO中的BKM120。2 µL稀释的BKM120溶液加到细胞培养基上, (浓度为0-6.6 µM)。等体积(100 µL)溶液加到96孔板中,在37oC下温育3天。使用Trilux读取荧光值而测定抑制细胞增殖的效果
    (Only for Reference)
动物实验:[1]
- 合并
  • Animal Models: 携带U87MG 和A2780移植瘤的雌性裸鼠
  • Dosages: ~60 mg/kg
  • Administration: 每天口服处理
    (Only for Reference)

溶解度 (25°C)

体外 DMSO 82 mg/mL (199.8 mM)
Ethanol 2 mg/mL (4.87 mM)
Water Insoluble
体内 从左到右依次将纯溶剂加入产品,现配现用(数据来自Selleck实验检测而非文献):
5% DMSO+30% PEG 300+ddH2O
15mg/mL

* 溶解度检测是由Selleck技术部门检测的,可能会和文献中提供的溶解度有所差异,这是由于生产工艺和批次不同产生的正常现象。请按照顺序依次加入各个纯溶剂。

化学数据

分子量 410.39
化学式

C18H21F3N6O2

CAS号 944396-07-0
储存条件 粉状
溶于溶剂
别名 NVP-BKM120

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系Selleck为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % ddH2O
计算重置

计算器

摩尔浓度计算器

摩尔浓度计算器

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子量 (g/mol)

摩尔浓度计算公式

  • 质量
    浓度
    体积
    分子量

*在配置溶液时,请务必参考Selleck产品标签上、SDS / COA(可在Selleck的产品页面获得)批次特异的分子量使用本工具。

稀释计算器

稀释计算器

用本工具协助配置特定浓度的溶液,使用的计算公式为:

开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

稀释公式一般简略地表示为: C1V1 = C2V2 ( 输入 输出 )

  • C1
    V1
    C2
    V2

在配置溶液时,请务必参考Selleck产品标签上、SDS / COA(可在Selleck的产品页面获得)批次特异的分子量使用本工具。.

连续稀释计算器方程

  • 连续稀释

  • 计算结果

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
分子量计算器

分子量计算器

通过输入化合物的化学式来计算其分子量:

总分子量:g/mol

注:化学分子式大小写敏感。C10H16N2O2 c10h16n2o2

摩尔浓度计算器

质量 浓度 体积 分子量
计算

临床试验信息

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT04338399 Recruiting Drug: Buparlisib & Paclitaxel Head and Neck Cancer Adlai Nortye Biopharma Co. Ltd. December 12 2020 Phase 3
NCT02614508 Terminated Drug: Buparlisib|Drug: Ibrutinib|Biological: Ofatumumab Recurrent Chronic Lymphocytic Leukemia|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Small Lymphocytic Lymphoma Emory University|Novartis January 2016 Phase 1
NCT01613677 Withdrawn Drug: BKM120 Treatment for Metastatic or Locally Advanced Cervical Cancer Novartis Pharmaceuticals|Novartis November 2015 Phase 2

技术支持

在订购、运输、储存和使用我们的产品的任何阶段,您遇到的任何问题,均可以通过拨打我们的热线电话400-668-6834,或者技术支持邮箱tech@selleck.cn,直接联系到我们。我们会在24小时内尽快联系您。

操作手册

如果有其他问题,请给我们留言。

  • * 必填项

PI3K Signaling Pathway Map

PI3K Inhibitors with Unique Features

相关PI3K产品

Tags: 购买Buparlisib (BKM120) | Buparlisib (BKM120)供应商 | 采购Buparlisib (BKM120) | Buparlisib (BKM120)价格 | Buparlisib (BKM120)生产 | 订购Buparlisib (BKM120) | Buparlisib (BKM120)代理商
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID